Allezoe (ALZM) Announces New Management for SureScreen Medical
March 15 2012 - 9:30AM
Marketwired
Allezoe Medical Holdings (OTCBB:ALZM) today announced that Caroline
Pinell has agreed to join the Company on a full time basis and has
been named as the President and CEO of SureScreen Medical, Inc., a
wholly-owned subsidiary of the Company. She will also serve as
President and Chief Operating Officer for Allezoe Medical and will
remain as a member of the Board of Directors. SureScreen recently
acquired the exclusive license to develop and market patent
pending, advanced, "see and treat" diagnostic technology for HPV,
the world's leading sexually transmitted infection (STI). Under the
terms of the license, SureScreen will develop and market products
worldwide using the technology in return for a fixed royalty to AVM
Licensing Corp., commencing on sales of products using the
technology.
Caroline Pinell has been a high level operations consultant to a
wide range of healthcare industry clients, including hospitals,
independent physician associations, physician groups and networks,
medical practices, attorneys, and Medicare and Medicaid health
plans. Pinell has extensive experience developing and implementing
strategic business plans and focused marketing measures for
healthcare organizations, as well as overseeing healthcare
compliance and licensing. Ms. Pinell attended the MD program at the
University of Texas Health Science Center and earned a law degree
from the South Texas College of Law.
From 2005 to the present, she has been an Independent Healthcare
Consultant, serving as a as a high level healthcare operations
consultant to various clients, including Hospitals, Independent
Physician Associations, Physician Groups and Networks, Medical
Practices, Attorneys, and various Medicare and Medicaid Health
Plans.
From 2008 to 2009, she was President and CEO of ATRIO Health
Plans, a Medicare Advantage (MA-PD) Plan located in Oregon. It
services three counties including Douglas, Coos, and Klamath
Counties with expansion plans in place for Washington County. The
Plan covers approximately 4500 lives with significant growth
expected over the next three years. The Provider Network included
99% of all providers in each the counties it currently
services.
From 2006 to 2008, she was Vice President and Executive Director
of Physician Relations, Business development and Managed Care at
HCA-Bayshore Medical Center, a 463 Bed acute care community
hospital serving Pasadena, Texas and its surrounding areas. The
Medical Staff includes over 400 physicians in various specialties
including internal medicine, cv surgery, neurosurgery, oncology,
and critical care intensivists.
From 2005 to 2006, she was Chief Operating Officer of IntegraNet
Physicians Resources, Inc., a privately owned independent physician
association with a citywide provider network that exceeds 750
physicians in the Houston area. It currently houses credentialing,
contracting, provider relations, and claims management departments.
The company holds contracts with four Health Plans that represent
multiple Medicare and Medicaid products.
From 2000 to 2005, she was Vice President of Operations for
Primary Medical Care, Memorial Clinical Associates and MCA
Research, three affiliated healthcare operations in the Houston,
Texas area.
Michael Gelmon, CEO of Allezoe Medical Holdings, stated: "We are
fortunate to have obtained the fill time services of a medical and
legal professional of the caliber of Caroline Pinell to join us and
to manage our SureScreen Medical subsidiary. We are confident that
the HPV technology licensed by SureScreen will be successfully
developed and brought to the market with Caroline Pinnell's
guidance."
FORWARD LOOKING STATEMENT
Certain statements contained herein and subsequent oral
statements made by and on behalf of ALZM may contain "forward
looking statements" within the meaning of the Private Securities
Litigation Reform Act of 1995. Such forward looking statements are
identified by words such as "intends", "anticipates", "believes",
"expects", and "hopes" and includes, without limitation, statements
regarding ALZM's plan of business operations, product research and
development activities, anticipated revenues and expenses and
potential contractual arrangements and obligations. Also, our
management may make forward-looking statements orally to investors,
analysts, the media and others. Any statements made in this news
release about an action, event or development, are forward-looking
statements. Such statements are based upon assumptions that in the
future may prove not to have been accurate and are subject to
significant risks and uncertainties. Such statements are subject to
a number of assumptions, risks and uncertainties, many of which are
beyond the control of the Company. These risks and others are
included from time to time in documents we file with the Securities
and Exchange Commission, including but not limited to, its Form
10-Ks, Form 10-Qs and Form 8-Ks. Other unknown or unpredictable
factors also could have material adverse effects on our future
results. Accordingly, you should not place undue reliance on these
forward-looking statements. Although the Company believes that the
expectations reflected in the forward-looking statements are
reasonable, it can give no assurance that its forward-looking
statements will prove to be correct. Investors are cautioned that
any forward-looking statements are not guarantees of future
performance and actual results or developments may differ
materially from those projected. The forward-looking statements in
this press release are made as of the date hereof. The Company
undertakes no obligation to update or correct its own
forward-looking statements, except as required by law or those
prepared by third parties that are not paid by the Company. The
Company's SEC filings are available at http://www.sec.gov.
Contacts: Allezoe Medical Holdings, Inc. Media
Departmentmedia@allezoe.com